neostigmine has been researched along with Pharyngitis in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Pharyngitis: Inflammation of the throat (PHARYNX).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, ES | 1 |
| Oh, AY | 1 |
| Koo, BW | 1 |
| Hwang, JW | 1 |
| Han, JW | 1 |
| Seo, KS | 1 |
| Ahn, SH | 1 |
| Jeong, WJ | 1 |
| CUPIC, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison Sugammadex With Neostigmine in Laryngeal Microsurgery.[NCT02330172] | 44 participants (Actual) | Interventional | 2014-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
We measured recovery time ffrom the injection of neostigmine or sugammadex to TOF ratio 0.9 (NCT02330172)
Timeframe: from the injection of neostigmine or sugammadex up to 30 minutes
| Intervention | minute (Mean) |
|---|---|
| Rocuronium 0.45 - Neostigmine | 9.9 |
| Rocuronium 0.9 - Sugammadex | 2.1 |
"Definitions for evaluation of Laryngoscopycondition.~: Easy = jaw relaxed, no resistance to blade insertion, fair = jaw not fully relaxed, slight resistance to blade insertion, difficult = poor jaw relaxation, active resistance of the patient to laryngoscopy.~Variables Excellent Good Poor" (NCT02330172)
Timeframe: At the beginning of surgery, the surgeon rated the laryngoscopy condition
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| Difficult | Fair | Easy | |
| Rocuronium 0.45 - Neostigmine | 1 | 11 | 9 |
| Rocuronium 0.9 - Sugammadex | 0 | 0 | 19 |
1 trial available for neostigmine and Pharyngitis
| Article | Year |
|---|---|
Comparison of reversal with neostigmine of low-dose rocuronium vs. reversal with sugammadex of high-dose rocuronium for a short procedure.
Topics: Adult; Aged; Anesthesia Recovery Period; Anesthesia, General; Attitude of Health Personnel; Dose-Res | 2017 |
1 other study available for neostigmine and Pharyngitis
| Article | Year |
|---|---|
[Pharyngo-otitis in infant and child].
Topics: Child; Gastric Juice; Humans; Infant; Neostigmine; Otitis; Otitis Media; Pharyngitis; Pilocarpine | 1953 |